GABAPENTIN
- Product NDC
- 68071-1212
- 11-digit product format
- 680711212
- Labeler code
- 68071
- Product ID
- 68071-1212_bafe6c51-96ec-7414-e053-2995a90a8488
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA090705
- Marketing category
- ANDA
- Marketing start
- 2016-06-29
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cdc2ae60-922e-452d-a42f-787fe4e2ed06 | Product name | 1 | 20250123 |
| 7059096a-4b9f-36c2-db50-bb5c723e6e9e | Product name | 2 | 20250114 |
| a62a50ac-1535-4461-9768-8ae703e2e9fb | Product name | 1 | 20210525 |
| fa3f0129-3502-889f-f424-3a37727959e7 | Product name | 9 | 20181206 |
| 77d89e4c-f57f-326d-d7aa-787f8eebbd2b | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| bc07ef78-e82d-0c19-31f4-31f263780582 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-1212-1 | GABAPENTIN | 120 in 1 BOTTLE | CAPSULE | 120 | 2 | |
| 68071-1212-2 | GABAPENTIN | 270 in 1 BOTTLE | CAPSULE | 270 | 2 | |
| 68071-1212-3 | GABAPENTIN | 30 in 1 BOTTLE | CAPSULE | 30 | 2 | |
| 68071-1212-4 | GABAPENTIN | 84 in 1 BOTTLE | CAPSULE | 84 | 2 | |
| 68071-1212-5 | GABAPENTIN | 14 in 1 BOTTLE | CAPSULE | 14 | 2 | |
| 68071-1212-6 | GABAPENTIN | 60 in 1 BOTTLE | CAPSULE | 60 | 2 | |
| 68071-1212-7 | GABAPENTIN | 7 in 1 BOTTLE | CAPSULE | 7 | 2 | |
| 68071-1212-8 | GABAPENTIN | 180 in 1 BOTTLE | CAPSULE | 180 | 2 | |
| 68071-1212-9 | GABAPENTIN | 90 in 1 BOTTLE | CAPSULE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-1212 | GABAPENTIN CAPSULE [NUCARE PHARMACEUTICALS, INC.] | 2 | Legacy NDC, 9 package rows | 20210211_4b82425c-dffc-61db-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310431 | gabapentin 300 MG Oral Capsule | PSN | 4b82425c-dffc-61db-e054-00144ff88e88 | 2 |
| 310431 | gabapentin 300 MG Oral Capsule | SCD | 4b82425c-dffc-61db-e054-00144ff88e88 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-1212-1 | 68071121201 | 120 CAPSULE in 1 BOTTLE (68071-1212-1) | 120 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-1212-2 | 68071121202 | 270 CAPSULE in 1 BOTTLE (68071-1212-2) | 270 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-1212-3 | 68071121203 | 30 CAPSULE in 1 BOTTLE (68071-1212-3) | 30 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-1212-4 | 68071121204 | 84 CAPSULE in 1 BOTTLE (68071-1212-4) | 84 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-1212-5 | 68071121205 | 14 CAPSULE in 1 BOTTLE (68071-1212-5) | 14 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-1212-6 | 68071121206 | 60 CAPSULE in 1 BOTTLE (68071-1212-6) | 60 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-1212-7 | 68071121207 | 7 CAPSULE in 1 BOTTLE (68071-1212-7) | 7 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-1212-8 | 68071121208 | 180 CAPSULE in 1 BOTTLE (68071-1212-8) | 180 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-1212-9 | 68071121209 | 90 CAPSULE in 1 BOTTLE (68071-1212-9) | 90 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |